Telomir Pharmaceuticals, Inc. (TELO)
0.88
+0.10
(+12.81%)
USD |
NASDAQ |
Nov 06, 10:29
Telomir Pharmaceuticals Market Cap : 60.52M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 53.65M |
| November 04, 2026 | 60.18M |
| November 03, 2026 | 62.59M |
| November 02, 2026 | 62.94M |
| October 30, 2026 | 64.32M |
| October 29, 2026 | 66.31M |
| October 28, 2026 | 69.46M |
| October 27, 2026 | 70.15M |
| October 26, 2026 | 68.67M |
| October 23, 2026 | 67.06M |
| October 22, 2026 | 69.46M |
| October 21, 2026 | 70.15M |
| October 20, 2026 | 69.46M |
| October 19, 2026 | 71.53M |
| October 16, 2026 | 72.21M |
| October 15, 2026 | 72.21M |
| October 14, 2026 | 72.21M |
| October 13, 2026 | 74.96M |
| October 12, 2026 | 75.65M |
| October 09, 2026 | 77.03M |
| October 08, 2026 | 79.09M |
| October 07, 2026 | 77.03M |
| October 06, 2026 | 82.53M |
| October 05, 2026 | 83.22M |
| October 02, 2026 | 81.15M |
| Date | Value |
|---|---|
| October 01, 2026 | 80.47M |
| September 30, 2026 | 82.53M |
| September 29, 2026 | 80.47M |
| September 28, 2026 | 82.53M |
| September 25, 2026 | 84.59M |
| September 24, 2026 | 83.22M |
| September 23, 2026 | 83.91M |
| September 22, 2026 | 85.97M |
| September 21, 2026 | 85.28M |
| September 18, 2026 | 84.59M |
| September 17, 2026 | 77.03M |
| September 16, 2026 | 77.72M |
| September 15, 2026 | 80.47M |
| September 14, 2026 | 80.47M |
| September 11, 2026 | 80.47M |
| September 10, 2026 | 81.15M |
| September 09, 2026 | 83.91M |
| September 08, 2026 | 81.84M |
| September 04, 2026 | 79.78M |
| September 03, 2026 | 79.78M |
| September 02, 2026 | 77.03M |
| September 01, 2026 | 75.65M |
| August 31, 2026 | 77.03M |
| August 28, 2026 | 78.40M |
| August 27, 2026 | 81.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.605B |
| Corcept Therapeutics, Inc. | 8.031B |
| Veru, Inc. | 35.29M |
| Johnson & Johnson | 655.77B |
| Eli Lilly & Co. | 1.286T |
Market Cap Related Metrics
| PEG Ratio | -0.0143 |
| Price to Book Value | 12.02 |
| Price | 0.88 |
| Earnings Yield | -103.3% |
| PEGY Ratio | -0.0143 |